See more : Forum Mobile, Inc. (FRMB) Income Statement Analysis – Financial Results
Complete financial analysis of PT Merck Tbk (MERK.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Merck Tbk, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Burtech Acquisition Corp. (BRKH) Income Statement Analysis – Financial Results
- Viva Entertainment Group Inc. (OTTV) Income Statement Analysis – Financial Results
- Suzhou Douson Drilling & Production Equipment Co.,Ltd. (603800.SS) Income Statement Analysis – Financial Results
- Elevate Uranium Ltd (EL8.AX) Income Statement Analysis – Financial Results
- Reborn Coffee, Inc. (REBN) Income Statement Analysis – Financial Results
PT Merck Tbk (MERK.JK)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.merckgroup.com/id-id
About PT Merck Tbk
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 961.43B | 1,124.60B | 1,064.39B | 655.85B | 744.63B | 611.96B | 1,156.65B | 1,034.81B | 983.45B | 863.21B | 1,193.95B | 929.88B | 918.53B | 795.69B | 751.40B | 637.13B | 547.24B | 487.60B | 386.35B |
| Cost of Revenue | 560.96B | 697.01B | 665.71B | 361.64B | 421.32B | 400.27B | 568.65B | 492.61B | 487.19B | 404.75B | 648.47B | 505.43B | 436.39B | 353.72B | 313.77B | 275.66B | 228.99B | 202.77B | 171.65B |
| Gross Profit | 400.47B | 427.59B | 398.68B | 294.21B | 323.31B | 211.69B | 587.99B | 542.19B | 496.26B | 458.46B | 545.48B | 424.44B | 482.14B | 441.97B | 437.63B | 361.48B | 318.24B | 284.83B | 214.69B |
| Gross Profit Ratio | 41.65% | 38.02% | 37.46% | 44.86% | 43.42% | 34.59% | 50.84% | 52.40% | 50.46% | 53.11% | 45.69% | 45.65% | 52.49% | 55.55% | 58.24% | 56.73% | 58.15% | 58.41% | 55.57% |
| Research & Development | 541.77M | 288.16M | 166.75M | 188.76M | 113.50M | 1.13B | 3.90B | 1.80B | 2.89B | 2.44B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 79.04B | 41.23B | 51.67B | 48.10B | 48.25B | 28.58B | 56.94B | 27.25B | 27.29B | 19.53B | 26.08B | 19.81B | 47.00B | 65.36B | 50.16B | 45.31B | 43.47B | 32.03B | 26.23B |
| Selling & Marketing | 121.94B | 51.61B | 35.41B | 33.44B | 64.13B | 66.19B | 175.10B | 164.89B | 148.38B | 128.96B | 137.33B | 124.07B | 236.56B | 222.88B | 186.02B | 176.01B | 150.92B | 133.26B | 106.47B |
| SG&A | 200.99B | 92.84B | 87.08B | 81.55B | 112.38B | 94.76B | 232.04B | 192.15B | 175.67B | 148.49B | 163.42B | 143.88B | 283.56B | 288.23B | 236.18B | 221.32B | 194.39B | 165.29B | 132.70B |
| Other Expenses | -786.85M | 97.45B | 119.99B | 101.80B | 83.80B | 2.58B | 3.22B | 133.61B | 131.54B | 106.96B | 153.26B | 140.53B | 3.77B | -1.19B | 0.00 | -223.65M | 0.00 | -38.11M | 417.77M |
| Operating Expenses | 200.74B | 190.58B | 207.24B | 183.53B | 196.30B | 165.56B | 381.65B | 327.56B | 310.09B | 257.89B | 316.68B | 284.40B | 287.33B | 287.04B | 236.18B | 221.32B | 194.39B | 165.29B | 132.70B |
| Cost & Expenses | 761.70B | 887.58B | 872.95B | 545.17B | 617.62B | 565.83B | 950.30B | 820.17B | 797.29B | 662.65B | 965.15B | 789.84B | 723.72B | 640.76B | 549.95B | 496.98B | 423.39B | 368.07B | 304.35B |
| Interest Income | 7.44B | 2.10B | 1.61B | 1.44B | 2.55B | 3.80B | 646.70M | 1.94B | 7.44B | 4.93B | 5.10B | 5.05B | 5.02B | 3.57B | 5.45B | 5.65B | 4.86B | 2.36B | 466.42M |
| Interest Expense | 4.04B | 3.40B | 2.64B | 3.97B | 2.24B | 722.44M | 3.36B | 323.34M | 17.17M | 303.09M | 418.00M | 382.78M | 422.81M | 792.98M | 899.79M | 289.63M | 489.33M | 373.31M | 608.30M |
| Depreciation & Amortization | 8.75B | 31.35B | 38.22B | 31.29B | 6.86B | 5.07B | 8.22B | 14.26B | 3.67B | 3.05B | 5.67B | 6.03B | -98.63B | -949.89M | 7.37B | 2.69B | 3.67B | 3.56B | 2.03B |
| EBITDA | 239.49B | 272.52B | 231.36B | 141.27B | 132.76B | 55.28B | 43.97B | 228.89B | 197.63B | 209.31B | 200.72B | 152.33B | 179.99B | 154.93B | 217.46B | 143.29B | 128.78B | 124.02B | 84.53B |
| EBITDA Ratio | 24.91% | 22.29% | 19.10% | 18.44% | 17.60% | 8.51% | 18.29% | 21.11% | 19.94% | 24.05% | 20.02% | 16.22% | 19.60% | 19.30% | 27.79% | 22.42% | 23.30% | 25.24% | 21.75% |
| Operating Income | 199.73B | 239.07B | 191.53B | 108.53B | 125.59B | 47.13B | 208.49B | 213.30B | 186.51B | 200.44B | 230.03B | 141.25B | 278.63B | 154.55B | 201.45B | 140.15B | 123.85B | 119.53B | 82.00B |
| Operating Income Ratio | 20.77% | 21.26% | 17.99% | 16.55% | 16.87% | 7.70% | 18.03% | 20.61% | 18.97% | 23.22% | 19.27% | 15.19% | 30.33% | 19.42% | 26.81% | 22.00% | 22.63% | 24.51% | 21.22% |
| Total Other Income/Expenses | 3.40B | -1.30B | -1.03B | -2.53B | 304.49M | 3.08B | -416.76M | 1.62B | 7.43B | 3.72B | 41.10B | 4.67B | 89.40B | 2.77B | 6.47B | 2.85B | 4.44B | 4.12B | 1.92B |
| Income Before Tax | 203.13B | 237.78B | 190.50B | 106.00B | 125.90B | 50.21B | 205.78B | 214.92B | 193.94B | 205.06B | 234.71B | 145.91B | 283.23B | 157.32B | 207.93B | 143.00B | 128.29B | 123.65B | 83.92B |
| Income Before Tax Ratio | 21.13% | 21.14% | 17.90% | 16.16% | 16.91% | 8.20% | 17.79% | 20.77% | 19.72% | 23.76% | 19.66% | 15.69% | 30.83% | 19.77% | 27.67% | 22.44% | 23.44% | 25.36% | 21.72% |
| Income Tax Expense | 24.89B | 57.94B | 58.84B | 34.10B | 47.64B | 12.83B | 61.11B | 61.07B | 51.40B | 54.68B | 59.26B | 38.11B | 52.07B | 38.52B | 61.23B | 44.39B | 38.80B | 37.09B | 26.22B |
| Net Income | 178.24B | 179.84B | 131.66B | 71.90B | 78.26B | 1,163.32B | 144.68B | 153.84B | 142.55B | 181.47B | 175.44B | 107.81B | 231.16B | 118.79B | 146.70B | 98.62B | 89.48B | 86.54B | 57.70B |
| Net Income Ratio | 18.54% | 15.99% | 12.37% | 10.96% | 10.51% | 190.10% | 12.51% | 14.87% | 14.49% | 21.02% | 14.69% | 11.59% | 25.17% | 14.93% | 19.52% | 15.48% | 16.35% | 17.75% | 14.93% |
| EPS | 397.86 | 401.42 | 293.89 | 160.50 | 174.68 | 2.60K | 323.00 | 343.00 | 2.46K | 406.60 | 391.60 | 240.65 | 516.00 | 265.15 | 327.45 | 220.15 | 199.75 | 193.15 | 128.80 |
| EPS Diluted | 397.86 | 401.42 | 293.89 | 160.50 | 174.68 | 2.60K | 323.00 | 343.00 | 2.46K | 406.60 | 391.60 | 240.65 | 516.00 | 265.15 | 327.45 | 220.15 | 199.75 | 193.15 | 128.80 |
| Weighted Avg Shares Out | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 57.87M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M |
| Weighted Avg Shares Out (Dil) | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 57.87M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M | 448.00M |
Source: https://incomestatements.info
Category: Stock Reports